Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease
This study has been completed.
Study NCT00548912 Information provided by West Penn Allegheny Health System
First Received: October 23, 2007 No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Failure, Chronic
Additional conditions recognized in this trial
Hypertrophy, Left Ventricular
Kidney Failure
More general conditions related to this trial
Cardiomegaly
Cardiovascular Diseases
Heart Diseases
Hypertrophy
Kidney Diseases
Pathological Conditions, Anatomical
Renal Insufficiency
Renal Insufficiency, Chronic
Urologic Diseases
Interventions listed in this trial
Spironolactone
More general drug interventions related to this trial
Aldosterone Antagonists
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
West Penn Allegheny Health System
Back to top of Main Content
